146 related articles for article (PubMed ID: 34280530)
1. Early diagnosis of kala-azar in Bangladesh: Findings from a population based mixed methods research informing the post-elimination era.
Rahman KM; Olsen A; Harley D; Samarawickrema IVM; Butler CD; Zahid K; Sumon SA; Mondal D; Luby SP; Sleigh AC
Parasitol Int; 2021 Dec; 85():102421. PubMed ID: 34280530
[TBL] [Abstract][Full Text] [Related]
2. Performance of kala-azar surveillance in Gaffargaon subdistrict of Mymensingh, Bangladesh.
Rahman KM; Samarawickrema IV; Harley D; Olsen A; Butler CD; Sumon SA; Biswas SK; Luby SP; Sleigh AC
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003531. PubMed ID: 25860258
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Hematological Features of Visceral Leishmaniasis at Mymensingh Medical College Hospital.
Malek MS; Robi IH; Islam MS; Kabir MA; Uddin MZ; Sumon SM; Siddiqui NI
Mymensingh Med J; 2020 Oct; 29(4):879-886. PubMed ID: 33116091
[TBL] [Abstract][Full Text] [Related]
4. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.
Das VNR; Siddiqui NA; Bhunia GS; Pandey K; Sinha SK; Ansari MZ; Topno RK; Lal CS; Ranjan A; Singh VP; Das P
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009598. PubMed ID: 34428232
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh.
Sultana A; Zakaria SM; Bhuiyan SI; Habib A; Dey SK; Rahman M; Basher A
Mymensingh Med J; 2012 Jul; 21(3):529-32. PubMed ID: 22828555
[TBL] [Abstract][Full Text] [Related]
6. "
Sunyoto T; Adam GK; Atia AM; Hamid Y; Babiker RA; Abdelrahman N; Vander Kelen C; Ritmeijer K; Alcoba G; den Boer M; Picado A; Boelaert M
Am J Trop Med Hyg; 2018 Apr; 98(4):1091-1101. PubMed ID: 29488462
[TBL] [Abstract][Full Text] [Related]
7. Elimination of Kala-Azar from the Southeast Asia Region.
Bhattacharya SK; Dash AP
Am J Trop Med Hyg; 2017 Apr; 96(4):802-804. PubMed ID: 28115678
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
Mathur P; Samantaray J; Chauhan NK
Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Knowledge, Attitudes, and Practices toward Kala-azar in an Endemic District in Bangladesh: A Cross-Sectional Survey.
Faria S; Hossain SM; Islam MS; Chowdhury V; Chowdhury R
Am J Trop Med Hyg; 2023 Apr; 108(4):783-790. PubMed ID: 36878211
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological characteristics of sixty five cases of Kala-azar attending to a laboratory in Mymensingh.
Talukder SI; Huq MH; Rahman S; Haque MA; Sarker CB; Ali MS
Mymensingh Med J; 2003 Jul; 12(2):89-92. PubMed ID: 12894039
[TBL] [Abstract][Full Text] [Related]
11. Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.
Mondal D; Nasrin KN; Huda MM; Kabir M; Hossain MS; Kroeger A; Thomas T; Haque R
PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957193
[TBL] [Abstract][Full Text] [Related]
12. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
Hossain MS; Kumar A; Hossain AFMA; Mahshin M; Sharma A; Hossain MA; Sharma V; Haque R; Shamsuzzaman AKM; Maruf S; Ghosh P; Ahuja V; Mondal D
Infect Dis Poverty; 2018 Aug; 7(1):80. PubMed ID: 30099967
[TBL] [Abstract][Full Text] [Related]
13. Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programme.
Siddiqui NA; Pandey K; R Das VN; Sinha SK; Verma RB; Lal CS; Ali V; Topno RK; Dikhit MR; Das P
J Vector Borne Dis; 2019; 56(4):315-322. PubMed ID: 33269731
[TBL] [Abstract][Full Text] [Related]
14. Intensely clustered outbreak of visceral leishmaniasis (kala-azar) in a setting of seasonal migration in a village of Bihar, India.
Kumar A; Saurabh S; Jamil S; Kumar V
BMC Infect Dis; 2020 Jan; 20(1):10. PubMed ID: 31906924
[TBL] [Abstract][Full Text] [Related]
15. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.
Islam S; Kenah E; Bhuiyan MA; Rahman KM; Goodhew B; Ghalib CM; Zahid MM; Ozaki M; Rahman MW; Haque R; Luby SP; Maguire JH; Martin D; Bern C
Am J Trop Med Hyg; 2013 Aug; 89(2):345-53. PubMed ID: 23817330
[TBL] [Abstract][Full Text] [Related]
17. Present situation of vector-control management in Bangladesh: a wake up call.
Mondal D; Alam MS; Karim Z; Haque R; Boelaert M; Kroeger A
Health Policy; 2008 Sep; 87(3):369-76. PubMed ID: 18342389
[TBL] [Abstract][Full Text] [Related]
18. Immunochromatographic (rK39) strip test in the diagnosis of visceral leishmaniasis in Bangladesh.
Sarker CB; Momen A; Jamal MF; Siddiqui NI; Siddiqui FM; Chowdhury KS; Rahman S; Talukder SI
Mymensingh Med J; 2003 Jul; 12(2):93-7. PubMed ID: 12894040
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of visceral leishmaniasis in India.
Bora D
Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of latex agglutination test (KAtex) for early diagnosis of kala-azar.
Ahsan MM; Islam MN; Mollah AH; Hoque MA; Hossain MA; Begum Z; Islam MT
Mymensingh Med J; 2010 Jul; 19(3):335-9. PubMed ID: 20639822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
